ADAR1 Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Sell |
33,143
-38,000
| -53% | -$2.03M | 0.27% | 56 |
|
|
2025
Q1 | $2.88M | Buy |
71,143
+55,836
| +365% | +$2.26M | 0.53% | 46 |
|
|
2024
Q4 | $426K | Sell |
15,307
-7,700
| -33% | -$214K | 0.09% | 111 |
|
|
2024
Q3 | $660K | Sell |
23,007
-2,500
| -10% | -$71.7K | 0.11% | 93 |
|
|
2024
Q2 | $598K | Buy |
25,507
+23,700
| +1,312% | +$556K | 0.11% | 84 |
|
|
2024
Q1 | $45.6K | Sell |
1,807
-14,193
| -89% | -$359K | 0.01% | 168 |
|
|
2023
Q4 | $374K | Buy |
+16,000
| New | +$374K | 0.13% | 59 |
|